Data-Driven Insights

April 1, 2014   |   Brandon Underwood

Did You Miss Our Webcast on Outside in Order Management with Supply Chain Insights?

Order Management Webcast Now Available On-Demand

Did you miss our co-hosted webcast on March 20th entitled, "Outside In Order Management," with Lora Cecere, Founder & CEO of Supply Chain Insights? No worries! It is now available on-demand. In the webcast, Lora took us on a deep dive into the new "outside in" methodology of using actual channel data to make informed order decisions. Lora covered all the bases and went into depth on how this new methodology ultimately helps to advance inventory turns and improves operating margins, as well as how suppliers can use advanced analytics to sense order flows and yield exceptions to drive a better supply chain response.

Read More

Tags: ,


March 27, 2014   |   Brandon Underwood

Registration is Now Open for The 2014 DNA Innovation Summit

Register today for the 2014 DNA Innovation Summit!

We are excited to announce that registration is now officially open for the 2014 DNA Innovation Summit! This year's event is being held Monday, September 8 through Wednesday, September 10 at the Omni William Penn Hotel in Pittsburgh, PA. This year's event will be the biggest and best yet! Not only will we be focusing on Demand Network Analytics (DNA), our suite of cloud-based informed applications, but we will also feature several sessions by industry experts on channel data trends within the pharmaceutical industry.

Read More

Tags:


March 25, 2014   |   Josh Halpern

What Happens When Doctors Start Asking Who Makes Your Generic?

Who makes your generic?

I recently read an article by Toni Clarke and Bill Berkrot, "Unease grows among US doctors over Indian drug quality." The piece raised some interesting points around the quality of imported drugs and the fact that doctors are starting to question the origin of the drugs they are prescribing to their patients. Recently, the FDA banned the importation of products from certain pharmaceutical manufacturers due to quality control problems, including data manipulation and sanitation. According to the article, "Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration."

Read More

Tags: , , ,


March 18, 2014   |   Kevin Leininger

Informed Applications: The Next Generation Beyond Analytics – Part Two

Kevin E. Leinger IntegriChain CEO

Kevin Leininger is CEO at IntegriChain. He has spent the last 20 years building and launching software and services companies in the financial services, petroleum, and pharmaceutical industries, and he is extremely passionate about the ways that data can transform business processes through the power of technology. What Are Informed Applications The pace of business is accelerating and companies are struggling to keep up with the need for more rapid decision-making and action taking to support it. The problem with legacy applications and analytics is that they are not built to support the vast majority of decisions that need to be made by an organization on a daily or weekly basis.

Read More

Tags:


March 11, 2014   |   Brandon Underwood

Beyond the Retail Pharmacy

Full Visibility into all Non-Retail Classes of Trade

Many pharmaceutical manufacturers have struggled to gain strong demand visibility for their products inside of non-retail pharmacies and other points of care. Others would have liked to use EDI 867 data for sales force reporting or incentive compensation but simply couldn't because the raw data didn't support that particular use. Until now.

Read More

Tags: , , ,


March 4, 2014   |   Brandon Underwood

Register Today! Outside In Order Management Free Webinar with Lora Cecere

Lora Cecere, Founder & CEO Supply Chain Insights

Register today for our Outside In Order Management Free Webinar being held Thursday, March 20th from 1pm to 2pm EST! This free webinar will be co-hosted by IntegriChain and Lora Cecere, Founder & CEO of Supply Chain Insights. If you're not familiar with Lora or Supply Chain Insights, I'd definitely suggest checking out both the Supply Chain Insights Blog and the Supply Chain Shaman blog. Both have some really awesome (and clever!) posts all related to the supply chain.

Read More

Tags: , , , , ,



February 18, 2014   |   Brandon Underwood

Survey Says: The Truth About Data, Out of Stocks, and Lost Sales

What does the Buyer-Supplier Connection look like in numbers?

A team from IntegriChain is attending ECRM Cough/Cold, Analgesics, and Allergy this week in Amelia Island, FL, and so we thought it would be worth taking a look back at the results of the Downstream Data & Buyer-Supplier Connection survey we conducted at the same conference last year. We spoke to over 50 manufacturers and asked a lot of questions about their forward supply chain. We asked things like what kind of data do you get from the channel? Are you currently doing Vendor Managed Inventory (VMI) with any of your accounts? How do out of stocks impact your business? The results were fascinating and more than a little eye-opening.

Read More

Tags: , , , , ,


February 13, 2014   |   Brandon Underwood

2013 Was A Great Year for IntegriChain & Demand Network Analytics (DNA)

IntegriChain is excited about momentum going into 2014!

2013 proved to be a year of strong corporate momentum and continued growth for IntegriChain and Demand Network Analytics (DNA). We saw all-time highs in revenue and ACV bookings, as well as positive EBITDA. Also, the release of DNA Order Management in October demonstrated its robust capacity for high transaction volumes, processing over half a million order lines in its first 3 months in production alone! This was very exciting for IntegriChain and has given us excellent momentum going into 2014.

Read More

Tags:


February 11, 2014   |   Brandon Underwood

Survey: Tell Us About Your Downstream Date

How are you using your downstream channel data?

IntegriChain is pleased to be working with Lora Cecere of Supply Chain Insights by sharing out a survey she’s conducting on uses of Downstream Data. In her own words: “The objective of this survey is to understand how companies are using or planning to use downstream data, how it will shape supply chain outcomes and how technologies can be used to maximize the potential of downstream data.”

Read More

Tags: , ,


adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand